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Jafar Jalaei1, Mehdi Fazeli1*, Hamid Rajaian1 and Seyed Shahram Shekarforoush2Abstract
Background: The emergence of antibacterial resistance against several classes of antibiotics is an inevitable consequence
of drug overuse. As antimicrobial resistance spreads throughout the globe, new substances will always be necessary to
fight against multidrug-resistant microorganisms. Venoms of many animals have recently gained attention in the search
for new antimicrobials to treat infectious diseases. Thefore, the present study aimed to study the antibacterial effects of
wasp (Vespa orientalis) crude venom.
Two gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis) and two gram-negative ones (Escherichia coli and
Klesiella pneumonia) were compared for their sensitivity to the venom by determining the inhibition zone (Kirby-Bauer
method) and minimum inhibitory concentration (MIC). A microbroth kinetic system based on continuous monitoring of
changes in the optical density of bacterial growth was also used for determination of antimicrobial activity.
Results: The venom exhibited a well-recognized antimicrobial property against the tested bacterial strains. The inhibition
zones were determined to be 12.6, 22.7, 22.4 and 10.2 mm for S. aureus, B. subtilis, E. coli and K. pneumonia, respectively.
The corresponding MIC values were determined to be 64, 8, 64 and 128 μg/mL, respectively. The MIC50 and MIC90 values
of the venom were respectively determined to be 63.6 and 107 μg/mL for S. aureus, 4.3 and 7.0 μg/mL for B. subtilis, 45.3
and 65.7 μg/mL for E. coli and 74.4 and 119.2 μg/mL for K. pneumonia. Gram-positive bacteria were generally more
sensitive to the venom than gram-negative ones.
Conclusions: Results revealed that the venom markedly inhibits the growth of both gram-positive and gram-negative
bacteria and could be considered a potential source for developing new antibacterial drugs.
Keywords: Wasp venom, Vespa orientalis, Antimicrobial activity, Minimum inhibitory concentrationBackground
Since the discovery of penicillin, numerous antibiotics have
been developed, primarily to treat bacterial or fungal infec-
tions. This fact constituted an important contribution to
human and animal health in the fight against infectious dis-
eases [1,2]. The widespread and/or inappropriate use of
antibiotics and chemicals against harmful microorganisms
has led to microbial resistance [3]. The emergence of
antibiotic-resistant organisms comprises a serious world-
wide problem. Recent findings on new antibiotic-resistant
organisms include multiple-drug resistant (MDR) Pseu-
domonas aeruginosa, MDR Acinetobacter baumannii
and New Delhi Metallo-β-Lactamase-1 (NDM-1) produ-
cing bacteria. Kumarasamy et al. [4] reported that the* Correspondence: mfazeli@shirazu.ac.ir
1Department of Pharmacology and Toxicology, School of Veterinary
Medicine, Shiraz University, Shiraz, Iran
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Dedication waiver (http://creativecommons.or
unless otherwise stated.‘superbugs’ that produce NDM-1 were resistant to almost
all antibiotics, except for polymyxin and tigecycline.
The augmentation in antibiotic resistance is a major chal-
lenge in medicine since not many new antibiotics are being
produced, and bacteria resistant to currently available drugs
are increasing. Seeking novel antibacterial substances and
antibiotic combination therapy are the strategic options to
overcome the MDR organisms [5,6]. Such initiative has
greatly driven the search for new antimicrobial agents with
novel mechanisms of action that are broadly effective and
less likely to induce antimicrobial resistance. These drugs
will be very important, particularly for the treatment of
immune compromised patients [7-9].
Despite tremendous advances in biological sciences, the
difficulty in identifying new mechanisms to kill bacterial
pathogens is discouraging. Thus, finding alternative sour-
ces of new drugs or prototypes is of major interest to
complementary medicine. In the hope of inventing noveltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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natural products are an important source of medicinal
compounds. A wide variety of organisms produces such
bioactive compounds and some of these natural substances
have been shown to be able to kill bacteria [10,11]. Venoms
of a vast number of animal species represent complex mix-
tures of compounds (ions, biogenic amines, polyamines,
polypeptide neurotoxins, cytolytic peptides, enzymes etc.)
responsible for various effects [12-15]. Venoms can also be
useful and valuable as pharmacological tools in drug re-
search, as potential drug design templates and as therapeutic
agents [16,17]. In recent years, venoms and venom compo-
nents from animals have shown potential antibacterial activ-
ity. These include venom of wasps, common honeybees,
spiders, snakes and scorpions [18-24]. Bearing in mind all
these facts, the present study was conducted to evaluate the
antibacterial activity of Vespa orientalis venom against dif-
ferent strains of gram-positive and gram-negative bacteria.
Methods
Venom extraction
Vespa orientalis specimens were collected from Abarkooh,
Yazd Province, Central Iran. Wasps were paralyzed at 4°C,
their venom glands were dissected and immersed in liquid
nitrogen. The glands were then crushed in a clean mortar
using pestle and liquid nitrogen. Twenty milliliters of 0.1 M
buffer phosphate (pH= 7.4) was added to the powdered
sample immediately after the evaporation of liquid nitrogen.
The suspension was then transferred into a clean tube and
further homogenized. Each tube containing the sample was
centrifuged at 8,000 × g for 15 minutes at 4°C. The super-
natant was transferred into another tube, lyophilized and
kept at −20°C until further assay.
Antimicrobial assay
Bacterial strains
The microorganisms used in the antibacterial screening as-
says were: gram-positive bacteria including Staphylococcus
aureus ATCC 6538 and Bacillus subtilis ATCC 1010649,
and gram-negative bacteria including Escherichia coli
ATCC 35218 and Klebsiella pneumonia ATCC 700603.
The bacteria were resuspended in tryptic soy broth (TSB),
incubated at 37°C overnight and stored at 4°C.
Agar disc diffusion method
The screening of antimicrobial activity of the crude venom
was carried out by agar disc diffusion method using Mueler-
Hinton agar (Merck, Germany). Similarly, tetracycline was
used for comparison. The bacterial inocula were prepared% Inhibition ¼ 100− OD of venom containing wells‐O
OD of the growth control‐OD
from the colonies of 24 hour-cultured bacteria on nutrient
agar. The inocula were adjusted with McFarland density to
obtain a final concentration of approximately 105 CFU/mL.
The Millipore filter paper discs (Millipore Corporation,
USA) were impregnated with either crude venom or tetra-
cycline (30 μg) and applied on the test media previously in-
oculated with each bacterial strain. Plates were incubated at
37°C and inhibition zones were measured after 24 hours of
incubation.
Broth microdilution method
The minimum inhibitory concentration (MIC) of crude
venom and tetracycline was also determined using conven-
tional broth microdilution method according to the CLSI
guidelines [25]. The adjusted bacterial suspensions were
added to each well of sterile microtiter plate containing the
test concentrations of antimicrobials (100 μL/well) in
Mueler-Hinton broth (MHB, Merck, Germany). Conse-
quently, final inoculum concentration of 1 × 105 CFU/mL
was obtained in each well and this plate was incubated for
24 hours at 37°C. The antimicrobial, a non-treated control,
and a sterility control were also used. Each assay was car-
ried out in triplicate. The lowest concentration of antibiotic
which inhibited the visible bacterial growth was selected as
MIC.
Growth curves
Antimicrobial activity of the crude venom was also ex-
amined using a 96-well sterile microtiter plate. The
crude venom and tetracycline (Sigma, Germany) were
serially diluted in MHB at concentrations of 1024, 512,
256, 128, 64, 32, 16, 8, 4 and 2 μg/mL and 16, 8, 4, 2, 1,
0.5, 0.25 and 0.125 μg/mL, respectively, in a final vol-
ume of 100 μL. Each well was inoculated with 10 μL of
the bacterial suspension containing 106 CFU/mL. Each
test was performed in triplicate. Three wells containing
bacterial suspension with no drug (growth control) and
three wells containing high concentration of tetracycline
(background control) were also included. Optical dens-
ities were measured for 24 hours at 37°C using a multi-
detection microplate reader (BioTek's PowerWave XS2,
USA) at 600 nm and recorded automatically for each
well every two hours. Turbidimetric growth curves were
obtained depending on the changes in the optical dens-
ity of bacterial growth for each drug concentration and
the drug-free growth control.
For the determination of MIC of crude venom and tetra-
cycline by the microbroth kinetic assay, the percentage of
growth at each drug concentration was calculated using the




Figure 1 Inhibitory effect of Vespa orientalis (VE: venom extract, 30 μg/disc) on the growth of different bacterial strains compared with
tetracycline (TE: tetracycline, 30 μg/disc).
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Vespa orientalis crude venom displayed a significant ef-
fect against different gram-positive and gram-negative
bacterial strains emplyed in this study. The correspond-
ing inhibition zones and MICs are listed in Figure 1 and
Table 1. The crude venom caused a marked inhibition in
bacterial growth with inhibition zones of 12.6, 22.7, 22.4
and 10.2 mm for S. aureus, B. subtilis, E. coli and K.
pneumonia respectively. The corresponding MICs of the
crude venom were respectively found to be 64, 8, 64 and
128 μg/mL using the conventional microdilution method
(Figure 1 and Table 1). Growth curves of different bacteria
during the incubation period in the presence of variousTable 1 Inhibitory effect of Vespa orientalis crude venom
on different strains of bacteria
Microorganisms Inhibition zone1 (mm) MIC2 (μL/mL)
Venom Tetracycline Venom Tetracycline
S. aureus 12.6 ± 0.313 28.1 ± 0.64 64 0.125
B. subtilis 22.7 ± 0.62 18.9 ± 0.14 8 0.125
E. coli 22.4 ± 0.68 19.3 ± 1.75 64 0.5
K. pneumonia 10.2 ± 0.12 12.1 ± 0.13 128 1
1Growth inhibition effects of venom and tetracycline was determined by disc
diffusion method (30 μg/disc). 2Minimum inhibitory concentrations were
obtained using serial dilutions. 3Mean ± SD (n = 3).concentrations of crude venom are presented in Figure 1.
The MIC50 and MIC90 of the crude venom against different
bacteria determined by microbroth kinetic system were
respectively 63.6 and 107 μg/mL for S. aureus; 4.3 and
7 μg/mL for B. subtilis; 45.3 and 65.7 μg/mL for E. coli;
74.4 and 119.2 μg/mL for K. pneumonia (Figures 2 and 3;
Table 2). All tested bacterial strains were found to be sus-
ceptible to the venom and among them, B. subtilis was the
most sensitive. In addition, the present findings indicate
that the crude venom is more effective against gram-
positive than gram-negative bacteria.Discussion
The present study describes the assessment of anti-
microbial effects of Vespa orientalis crude venom using
the microbroth kinetic system, which determines the ef-
fect of antibacterial agents by continuous monitoring of
bacterial culture optical density. The crude venom ex-
hibited activity against both gram-positive and gram-
negative bacteria and the MICs obtained in microbroth
kinetic system were similar to those found using con-
ventional broth microdilution method. A shorter incu-
bation period was required in the former technique and
percentages of growth inhibition were also measurable.
Figure 2 Growth curves of different bacterial strains exposed to Vespa orientalis crude venom during 24 hours. (A) Staphylococcus
aureus with 64 μg/mL, (B) Bacillus subtilis with 8 μg/mL, (C) Escherichia coli with 64 μg/mL and (D) Klesiella pneumonia with 128 μg/mL compared
with tetracycline with 16 μg/mL at 37°C. (blue diamond symbol): Control, (red square symbol): tetracyclin, (green triangle symbol): wasp
crude venom.
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classical antibiotics, naturally occurring antibacterial
agents are promising candidates in the search for novel
therapeutic agents [26]. Antibacterial property has been
reported for the venoms of a wide variety of animals in-
cluding venoms of snakes, scorpions, spiders, conus andFigure 3 Inhibitory effect of various concentrations of Vespa
orientalis crude venom on the growth of different
bacterial strains.wasps all of which are predatory or parasitic animals
[27-30]. However, the actual function of antimicrobial
agents in these venoms is not clear yet.
Venom components from predator wasps including hor-
nets (genera Vespa and Dolichovespula), yellow jackets
(genus Vespula) and paper wasps (genus Polistes) have been
extensively studied. Their toxins are complex mixtures of
amines, small peptides and high molecular weight proteins
such as enzymes, allergens and toxins [31-33]. Venoms
from these stinging wasps are important weapons both in
the defense of the colony and capture of prey. To the best
of our knowledge, only a few of its components have been
purified and characterized from parasitic Hymenoptera,
such as metalloproteinase, serpin, calreticulin-like protein,
aspartyl glucosaminidase-like protein and insecticidal toxins
[34-38].Table 2 Percent of inhibition action of different
concentrations (μg/mL) of Vespa orientalis crude venom
on the growth of different bacterial strains
Microorganisms % inhibition
10 20 40 50 60 80 90
S. aureus 20.2 31.1 52.8 63.6 74.5 96.2 107.0
B. subtilis 1.6 2.3 3.6 4.3 5.0 6.3 7.0
E. coli 24.9 30.0 40.2 45.3 50.4 60.6 65.7
K. pneumonia 29.6 40.8 63.2 74.4 85.6 108.0 119.2
Jalaei et al. Journal of Venomous Animals and Toxins including Tropical Diseases 2014, 20:22 Page 5 of 6
http://www.jvat.org/content/20/1/22The antimicrobial property of wasp venoms is mostly due
to their peptides. Amphipathic secondary structures with
net positive charges are essential to the biological activities
of peptides that interact with anionic components of bac-
terial membranes in different ways, sometimes resulting in
irreversible damage to the cell [39].
One of the major targets for antimicrobial agents is the
bacterial cell envelope, which is a complex, multiple macro-
molecular structures that undergoes highly ordered cycles
of synthesis and hydrolysis, facilitating cell division while
maintaining a protective barrier against environmental
stress. There are several different classes of antibiotics that
target specific cell envelope structures or enzymatic steps
of cell wall synthesis [40]. The biological membrane is a
highly dynamic, complicated system, which is composed of
weakly interacting protein molecules and lipids [41].
Results of the present study revealed that wasp venom is
more effective against gram-positive than gram-negative
bacteria, which might be related to the difference in cell en-
velope structure. Cell wall of bacteria comprises a complex
structure that is fundamentally different between gram-
positive and gram-negative bacteria. It consists of a polymer
of disaccharides cross-linked by short chain peptides, form-
ing a type of peptidoglycan. Cell wall in gram-positive bac-
teria is thick (15–80 nm), consisting of several layers of
peptidoglycans and molecules of teichoic acids. In contrast,
cell wall of gram-negative bacteria is relatively thin (10 nm)
in and is composed of a single layer of peptidoglycan sur-
rounded by a membranous structure (the outer membrane)
which may invariably contain lipopolysaccharides. Thus,
the outer membrane is more hydrophobic in gram-negative
than in gram-positive bacteria and constitutes a target for
being attacked by hydrophobic agents and other antibiotic
agents [42,43].Conclusions
Vespa orientalis crude venom efficiently inhibited the
growth of gram-positive and gram-negative bacterial
strains, even at a very low concentration when compared to
that of tetracycline. The crude venom showed to be more
efficient against gram-positive bacteria. As the crude venom
is comprised of different proteins and peptides, further in-
vestigation is required to determine the potential compo-
nents that could be used as antimicrobial drugs, especially
for treating antibiotic-resistant pathogens.Ethics committee approval
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